| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/30/2009 | EP2105504A2 Genes and proteins, and their use |
| 09/30/2009 | EP2105141A1 Short bioactive peptides and methods for their use |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2104738A2 Oligoribonucleotides and uses thereof |
| 09/30/2009 | EP2104671A2 Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors |
| 09/30/2009 | EP1692117B1 Oxazole derivatives of tetracyclines |
| 09/30/2009 | EP1465928B1 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/30/2009 | EP1407007B1 Attenuated circovirus |
| 09/30/2009 | EP1242122B1 Delivery of proteins across polar epithelial cell layers |
| 09/30/2009 | CN101547898A Transdermal delivery systems of beta-lactam antibiotics |
| 09/30/2009 | CN101547701A Enhancement of antitubercular activity of extracts of salicornia brachiata |
| 09/30/2009 | CN101544962A EV virus wide spectrum monoclonal antibody and its uses |
| 09/30/2009 | CN101544693A Recombined extrasin alpha 1 two-strand body protein and preparation method thereof |
| 09/30/2009 | CN101544690A Vegetable proteins extracted from P.octandra, preparation method and application thereof |
| 09/30/2009 | CN101544689A Leptospira vaccine candidate outer membrane protein |
| 09/30/2009 | CN101544670A Saccharine adefovir dipivoxil and preparation method thereof |
| 09/30/2009 | CN101544662A Cefotiam salt compound and pharmaceutical composition made therefrom |
| 09/30/2009 | CN101544661A Cefobutazine sodium compound and pharmaceutical composition made therefrom |
| 09/30/2009 | CN101544660A Cefixime compound and preparation method thereof |
| 09/30/2009 | CN101544634A 2-phenyl-3-substituted pyrazolo[1,5-a]pyridine derivatives, preparation method and application thereof |
| 09/30/2009 | CN101544632A Lamivudine diastereoselective synthesis method |
| 09/30/2009 | CN101544602A Fleroxacin lactate and preparation method thereof |
| 09/30/2009 | CN101543627A Traditional Chinese medicine composition of composite immune globulin for treating respiratory diseases of poultry |
| 09/30/2009 | CN101543601A Compound pharmaceutical composition for preventing and curing respiratory diseases in animals and preparation method thereof |
| 09/30/2009 | CN101543594A Mulberry-chrysanthemum oral liquid |
| 09/30/2009 | CN101543589A Compound pharmaceutical composition for curing virus diseases of animals and preparation method thereof |
| 09/30/2009 | CN101543571A Rhizoma paridis total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543570A Smilax glabra total aglycone oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543552A Traditional Chinese medicine preparation for treating lymph node enlargement |
| 09/30/2009 | CN101543535A Chinese medicinal preparation for treating cold |
| 09/30/2009 | CN101543513A Method using coupling of probiotic bacteria and virus for producing medicine |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543506A Compound antibiotic composition for preventing or treating Streptococcus suis |
| 09/30/2009 | CN101543499A Application of natural compound ursolic acid on antibiosis |
| 09/30/2009 | CN101543491A Application of m-chlorobenzoyl substituted dehydrosilybin for preparing antiviral drugs |
| 09/30/2009 | CN101543488A A medicine containing caffeic acid 3,4-dihydroxyl phenethyl ester and its uses |
| 09/30/2009 | CN101543484A Transdermal drug delivery preparation containing chitin or derivate thereof and preparation method thereof |
| 09/30/2009 | CN101543477A Sustained-release microsphere of chitosan-coated 3,5-dihydroxy-4-isopropyl toluylene and preparation method thereof |
| 09/30/2009 | CN101543476A A naringin solid dispersion and the preparation method, and the application thereof |
| 09/30/2009 | CN101543475A Tiamulin fumarate for veterinary use, lung-targeting microsphere of tiamulin fumarate salt and preparation method thereof |
| 09/30/2009 | CN101543469A Skin health care dew |
| 09/30/2009 | CN101543465A Cosmetic composition comprising imidopercarboxylic acid derivative and n-acylated amino acid ester |
| 09/30/2009 | CN100545161C Heterocyclic derivatives their preparing methods and uses |
| 09/30/2009 | CN100545150C Pyridine ring containing oxazolidinone compounds and preparation process and application thereof |
| 09/30/2009 | CN100544754C Anti inflammatory bacteria inhibiting medicinal composition and its preparation method |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/30/2009 | CN100544704C Topical anti-microbial compositions |
| 09/29/2009 | US7596455 Crystallization of IGF-1 |
| 09/29/2009 | US7595334 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 09/29/2009 | US7595324 Substituted thieno[3,2-D]pyrimidines as HIV inhibitors |
| 09/29/2009 | US7595309 For therapy of bacterial infections and neoplasms, |
| 09/29/2009 | US7595299 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/29/2009 | US7595298 Ala-Arg-Nal-Cys-Tyr-Arg-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg; viricide; low cytotoxicity |
| 09/29/2009 | US7595156 Genes for synthesis of FR-008 polyketides |
| 09/29/2009 | US7595058 Chlamydia antigens and vaccine uses of the protein |
| 09/29/2009 | US7595057 Streptococcus pyogenes antigens and corresponding DNA fragments |
| 09/29/2009 | US7595053 synthetic polypeptide biodrugs for treating viral disease; envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 09/29/2009 | US7595050 Human IGM monoclonal antibody capable of inducing apoptosis in HIV-infected cells |
| 09/29/2009 | US7595049 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy |
| 09/29/2009 | US7595048 Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1 |
| 09/29/2009 | US7595041 Treatment of malodour |
| 09/29/2009 | CA2519433C Augmentation of pyrithione activity or a polyvalent metal salt of pyrithione activity by zinc-containing layered material |
| 09/29/2009 | CA2481263C Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 09/29/2009 | CA2452036C 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity |
| 09/29/2009 | CA2446741C Ophthalmic drug delivery device |
| 09/29/2009 | CA2438891C Method for preparing optically active dihydropyrones |
| 09/29/2009 | CA2427812C Novel .beta.-lactam compounds and process for producing the same |
| 09/29/2009 | CA2347105C Controlled-release pharmaceutical composition with gastric residence |
| 09/29/2009 | CA2334730C Novel cyclosporins |
| 09/29/2009 | CA2322052C Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/29/2009 | CA2217178C Vaccines containing a saponin and a sterol |
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/28/2009 | CA2627903A1 Amphoteric microgels for the delivery of compounds to cells |
| 09/24/2009 | WO2009117540A1 Bridged heterocycles as hiv integrase inhibitors |
| 09/24/2009 | WO2009117278A2 Processes for preparing (amino-pyrazolopyridinyl)methoxy substituted biaryl ethers |
| 09/24/2009 | WO2009117035A1 Soluble forms of hendra and nipah virus f glycoprotein and uses thereof |
| 09/24/2009 | WO2009116944A1 Use of a substance for manufacturing of a medicament for treatment of common cold |
| 09/24/2009 | WO2009116604A1 Wickerol and process for production thereof |
| 09/24/2009 | WO2009116055A1 Lamivudine : zidovudine : water 1 : 1 : 1 cocrystal |
| 09/24/2009 | WO2009115972A1 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes |
| 09/24/2009 | WO2009115652A2 Composition and methods used during anti-hiv treatment |
| 09/24/2009 | WO2009115510A1 Antiviral formulation |
| 09/24/2009 | WO2009115287A1 Thiostrepton derivatives |
| 09/24/2009 | WO2009115252A2 Substituted pyrazolamides and the use thereof |
| 09/24/2009 | WO2009115245A1 Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci |
| 09/24/2009 | WO2009114924A1 Antiseptic compositions for the treatment of infections |
| 09/24/2009 | WO2009114921A1 INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES |
| 09/24/2009 | WO2009081152A3 Antimicrobial compounds |
| 09/24/2009 | WO2009062102A3 Compositions and methods for treatment of microbial disorders |
| 09/24/2009 | WO2009049013A3 Cholera vaccines |
| 09/24/2009 | WO2009040068A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040067A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040049A3 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
| 09/24/2009 | WO2009039248A3 Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 09/24/2009 | WO2009033681A3 Cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009033680A3 Galanin-like peptide alone or in combination with cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009032668A3 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 09/24/2009 | WO2009005674A3 Novel hiv reverse transcriptase inhibitors |